Related Experiment Video
Updated: Jun 19, 2026

Experimental Model to Evaluate Resolution of Pneumonia
Published on: February 17, 2023
A STUDY OF THE MECHANISM OF RECOVERY FROM LOBAR PNEUMONIA
R H Sia1, O H Robertson, S T Woo
1Hospital of The Rockefeller Institute for Medical Research, New York, and the Department of Medicine, Peking Union Medical College, Peking, China.
Abstract:
Employing a method devised for the investigation of natural immunity and experimental pneumococcus infection, a study has been made of the serum immune changes occurring during the course of lobar pneumonia due to Pneumococcus Types I and II and Group IV, in man. It was found that at the time of crisis or lysis the blood serum acquired constantly the property of promoting pneumococcus killing to a relatively marked degree. Other evidences of antipneumococcus reaction-mouse protection, opsonins, and agglutinins-were also demonstrable in the blood at this time. These immune changes appeared in the majority of cases at the beginning of recovery and failed to occur when the disease terminated fatally. The fact that these observations in human cases are practically identical with previous findings in the experimental disease in cats, enhances considerably the significance of the development of serum immune bodies at the time of crisis since in the experimental animal it was possible to show that the acquisition of passive immunity was associated with greatly increased antipneumococcus resistance.
Related Concept Videos
Pneumonia II: Pathophysiology
Pneumonia IV: Management
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Pneumonia I: Introduction
Pneumonia I: Introduction
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Pneumonia III: Complications and Assessment
Pneumothorax II: Pathophysiology
